Myomatous erythrocytosis syndrome

From WikiMD's Wellness Encyclopedia

Myomatous erythrocytosis syndrome is a rare medical condition characterized by the presence of uterine fibroids (myomas) and an associated increase in red blood cell mass, leading to erythrocytosis. This syndrome is notable for its unique combination of gynecological and hematological abnormalities.

Pathophysiology[edit | edit source]

The exact mechanism underlying myomatous erythrocytosis syndrome is not fully understood. However, it is believed that the uterine fibroids may produce erythropoietin, a hormone that stimulates the production of red blood cells in the bone marrow. This overproduction of erythropoietin leads to erythrocytosis, which is characterized by an elevated hematocrit and hemoglobin levels.

Clinical Presentation[edit | edit source]

Patients with myomatous erythrocytosis syndrome typically present with symptoms related to both the uterine fibroids and the increased red blood cell mass. Common symptoms include:

Diagnosis[edit | edit source]

The diagnosis of myomatous erythrocytosis syndrome involves a combination of clinical evaluation, laboratory tests, and imaging studies. Key diagnostic steps include:

Treatment[edit | edit source]

The treatment of myomatous erythrocytosis syndrome focuses on managing both the uterine fibroids and the erythrocytosis. Treatment options may include:

Prognosis[edit | edit source]

The prognosis for patients with myomatous erythrocytosis syndrome varies depending on the severity of the condition and the effectiveness of the treatment. Surgical removal of the uterine fibroids often leads to a resolution of the erythrocytosis and improvement in symptoms.

Related Pages[edit | edit source]

Contributors: Prab R. Tumpati, MD